Nolvadex

Dragon Pharma Nolvadex 20 — Tamoxifen Citrate SERM for PCT & Gynecomastia Defense

Dragon Pharma Nolvadex 20 delivers 20mg of pharmaceutical-grade tamoxifen citrate per tablet, serving as a cornerstone of post-cycle therapy and on-cycle breast tissue protection. As a selective estrogen receptor modulator, this compound is uniquely effective at restarting natural testosterone production while blocking estrogenic effects in specific tissues. Each batch is analytically verified for potency, ensuring precise dosing through critical recovery phases.

What is Dragon Pharma Nolvadex 20?

This oral SERM contains tamoxifen citrate, a non-steroidal selective estrogen receptor modulator originally developed for therapeutic hormone management. It has become the gold-standard ancillary in performance enhancement for both gynecomastia prevention and HPTA restoration.

Unlike aromatase inhibitors that suppress estrogen synthesis, this anti-estrogen competes for receptor binding in target tissues. It acts as an antagonist in breast and hypothalamic tissue while exhibiting partial agonist activity elsewhere, creating a unique pharmacological profile ideal for male hormone recovery.

Key Benefits / Effects

• Gynecomastia Prevention: This SERM blocks estrogen receptors in breast tissue, preventing glandular development and helping reverse early-stage gyno by cutting off the estrogenic growth signal.
• HPTA Stimulation: By antagonizing estrogen receptors in the hypothalamus and pituitary, it triggers increased GnRH release, driving LH and FSH production to restart testicular testosterone synthesis.
• Muscle Preservation: Accelerating endogenous testosterone recovery helps athletes retain lean tissue acquired during intensive training phases, preventing the catabolic crash common after suppressive cycles.
• Favorable Lipid Profile: Unlike aromatase inhibitors, this compound has a neutral to positive effect on cholesterol, often supporting HDL levels rather than suppressing them.
• On-Cycle Versatility: It can be deployed during active cycles at the first sign of nipple sensitivity, providing immediate receptor-level protection without crashing systemic estrogen.
• Stack Synergy: It pairs effectively with Clomid or enclomiphene for comprehensive PCT, addressing both pituitary stimulation and breast tissue protection simultaneously.

How Dragon Pharma Nolvadex 20 Works

Tamoxifen citrate functions as a competitive antagonist at estrogen receptor sites in breast tissue. By occupying these receptors without activating them, it prevents estradiol from triggering glandular proliferation, making it highly effective for both preventing and reversing early-stage gynecomastia.

Simultaneously, it blocks estrogenic feedback at the hypothalamus and pituitary gland. The brain perceives low estrogen and responds by increasing GnRH pulsatility, which stimulates the anterior pituitary to release luteinizing hormone and follicle-stimulating hormone. These gonadotropins travel to the testes, signaling Leydig cells to resume natural testosterone production and supporting spermatogenesis.

This dual-action mechanism—receptor blockade in breast tissue and negative feedback interruption in the brain—explains why this PCT compound remains the most trusted recovery agent in performance enhancement.

Usage Information

This anti-estrogen is supplied in 20mg oral tablets. For post-cycle therapy, standard protocols begin after long-acting exogenous compounds have cleared, typically 14–21 days following the final injection.

The classic 4-week PCT protocol starts at 40mg daily for weeks 1–2, then tapers to 20mg daily for weeks 3–4. Heavier or more suppressive cycles may extend the 20mg phase to weeks 5–6.

For on-cycle gynecomastia prevention, 10–20mg every other day or daily is used at the first sign of nipple sensitivity. Existing early-stage gyno may require 20–40mg daily until symptoms subside, followed by a maintenance dose. Always coordinate timing with the clearance rates of all compounds in your stack.

Quality & Manufacturing

Independent laboratory analysis confirms each tablet contains 21.05mg of active tamoxifen citrate, demonstrating exceptional batch consistency. This precision is critical because PCT success depends on maintaining exact serum levels throughout the recovery window.

Manufacturing under pharmaceutical-grade conditions ensures tablet uniformity and dissolution reliability. In the ancillary market, verified potency eliminates the risk of underdosed products that fail to stimulate adequate pituitary response or protect breast tissue effectively.

Possible Side Effects / Safety Information

• Reduced IGF-1 Levels: This SERM may slightly suppress insulin-like growth factor 1, an anabolic mediator. This is an acceptable trade-off during recovery phases when hormonal restoration takes priority over growth.
• Vision Changes: Rare reports include blurred vision or ocular discomfort. Discontinue immediately and seek medical evaluation if any visual disturbances occur.
• Hot Flashes: Some users experience mild thermoregulatory disruptions due to altered estrogen signaling, particularly during the first week of administration.
• Clotting Risk: Long-term therapeutic use is associated with a modest increase in thromboembolic events. Standard PCT durations of 4–6 weeks carry minimal risk for healthy adults.
• Not an AI Substitute: This compound does not reduce total estrogen synthesis. For controlling water retention or systemic estrogen during heavy aromatizing cycles, an aromatase inhibitor remains necessary.

Why Choose Dragon Pharma Nolvadex 20?

Recovering natural hormone production while protecting against gynecomastia requires a compound with decades of clinical and anecdotal validation. This selective estrogen receptor modulator offers a unique combination of pituitary stimulation and breast tissue antagonism that aromatase inhibitors cannot replicate.

Verified 20mg potency ensures predictable receptor saturation throughout PCT. For athletes who refuse to gamble their recovery on unregulated alternatives, pharmaceutical-grade manufacturing provides the consistency required for successful HPTA restoration.